Artemis Investment Management LLP
Source: SEC Form 13F · as of Mar 2026Artemis Investment Management LLP holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.65B in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$1.65B
BioSniper AIPage evidence connected
Prepared research question
What matters most for ASTRAZENECA PLC (AZN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 1,444,565 | $280.6M |
| ABBVAbbVie Inc. | 1,041,483 | $226.5M |
| PFEPFIZER INC | 7,392,508 | $207.6M |
| BMYBRISTOL MYERS SQUIBB CO | 2,885,298 | $175.0M |
| GMOptec International, Inc. | 1,643,705 | $122.5M |
| BIIBBIOGEN INC. | 571,571 | $104.8M |
| DGXQuest Diagnostics Incorporated | 447,274 | $87.7M |
| LLYELI LILLY & Co | 92,854 | $85.4M |
| CAHCardinal Health Inc. | 382,251 | $80.8M |
| GMEDGlobus Medical Inc. | 848,476 | $73.1M |
| ELANElanco Animal Health Inc | 2,841,535 | $68.0M |
| RGENREPLIGEN CORP | 421,788 | $49.7M |
| IQVIQVIA Holdings Inc. | 122,020 | $20.8M |
| JNJJOHNSON & JOHNSON | 65,168 | $15.9M |
| CORCencora Inc. | 44,434 | $14.0M |
| MEDPMedpace Holdings Inc. | 24,010 | $11.5M |
| MCKMcKesson Corporation | 11,942 | $10.3M |
| GILDGILEAD SCIENCES, INC. | 52,961 | $7.4M |
| HALOHALOZYME THERAPEUTICS, INC. | 110,860 | $7.2M |
| ANIPANI PHARMACEUTICALS INC | 15,451 | $1.2M |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 21,121 | $698K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.